Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Riders out

<< Previous

Bullboard Posts

Next >>

Post by Greenviolinoon Oct 26, 2023 5:07pm

174 Views

Post# 35703059

Riders out

So today was an opportunity for riders to get out of the issue, realizing the easy money is not happening. There is a lot of emotion being expressed on this board, understandingly so to a certain point. However, look at today's picture:
A few days ago, the company was valued at $75 million CAD market cap with around $20 million USD in cash.
Today, the same company is valued at $75 million CAD market cap with around $45 million USD in cash.
Trading at almost cash/share. Which company would you buy?
Forget dilution, focus on numbers.
And Lvesque is living on borrowed time. He will not survive this.

<< Previous

Bullboard Posts

Next >>

Nextech CEO provides company update on Amazon deal and more